During the past decade, Spedali Civili di Brescia conducted 287 clinical trials. In the 10-year time frame, 287 clinical trials started and 80 clinical trials were completed, i.e. on average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 144 clinical trials started and 62 clinical trials were completed. i.e. 43.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spedali Civili di Brescia" #1 sponsor was "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 30 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 18 trials sponsored, "Hoffmann-La Roche" with 15 trials sponsored, "Celgene" with 14 trials sponsored and "Boehringer Ingelheim" with 14 trials sponsored. Other sponsors include 320 different institutions and companies that sponsored additional 182 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spedali Civili di Brescia" #1 collaborator was "Università degli Studi di Brescia" with 7 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 6 trials as a collaborator, "Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia" with 5 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 5 trials as a collaborator and "Eli Lilly and Company" with 5 trials as a collaborator. Other collaborators include 308 different institutions and companies that were collaborators in the rest 270 trials.

According to Clinical.Site data, the most researched conditions in "Spedali Civili di Brescia" are "Heart Failure" (15 trials), "Multiple Myeloma" (10 trials), "Ovarian Cancer" (10 trials), "Breast Cancer" (8 trials) and "Lymphoma" (7 trials). Many other conditions were trialed in "Spedali Civili di Brescia" in a lesser frequency.

Most popular intervention types in "Spedali Civili di Brescia" are "Drug" (289 trials), "Device" (43 trials), "Other" (33 trials), "Procedure" (22 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "Rituximab" (20 trials), "Dexamethasone" (12 trials), "Paclitaxel" (11 trials) and "Atezolizumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Spedali Civili di Brescia" are 370 trials for "All" genders, 36 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Spedali Civili di Brescia". 2 are not yet recruiting, 99 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 171 completed trials in Spedali Civili di Brescia, 1 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Spedali Civili di Brescia, 22 "Phase 1" clinical trials were conducted, 125 "Phase 2" clinical trials and 149 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 35 trials that are defined as “Not Applicable".

Spedali Civili di Brescia has several departments that took part in Clinical trials: "AO Spedali Civili di Brescia- USD - TMO Adulti" - 15 trials, "ASST DEGLI SPEDALI CIVILI DI BRESCIA; Oncologia Medica" - 9 trials, "Ospedale Civile di Montichiari; Centro Sclerosi Multipla" - 7 trials, "ASST Spedali Civili di Brescia - Ematologia" - 65 trials, "Hospital "Spedali Civili"" - 4 trials, "Azienda Ospedaliera Spedali Civili; Scienze Neurologiche" - 3 trials, "A.O. Spedali Civili Di Brescia-P.O. Spedali Civili; Nefrologia" - 2 trials, "A.O.Spedali Civili; Ostetricia e Ginecologia" - 2 trials, "Asst Degli Spedali Civili Di Brescia; Reumatologia Ed Immunologia Clinica" - 2 trials, "Clinica Chirurgica, Università di Brescia - UOC Chirurgia Generale 3, ASST Spedali Civili di Brescia - Brescia" - 2 trials, "Department of Neurology ASST Spedali Civili Brescia" - 2 trials